Concurrent Antiviral and Immunosuppressive Activities of Leflunomide in Vivo

American Journal of Transplantation

Volumn 6, Issue 1, 2006, Pages 69-75

  Chong, A S ^a   Zeng, H ^a   Knight, D A ^b   Shen, J ^a   Meister, G T ^b   Williams, J W ^a   Waldman, W J ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antiviral; Cytomegalovirus; Leflunomide; Transplantation

Indexed keywords

CYCLOSPORIN A; GANCICLOVIR; LEFLUNOMIDE; TSUKUBAENOLIDE; URIDINE; ANTIVIRUS AGENT; C TYPE LECTIN, RAT CYTOMEGALOVIRUS; C-TYPE LECTIN, RAT CYTOMEGALOVIRUS; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLE DERIVATIVE; LECTIN; VIRUS PROTEIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INOCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; VIRUS CULTURE; VIRUS LOAD; ANIMAL; CHEMISTRY; CYTOMEGALOVIRUS; DRUG EFFECT; GRAFT REJECTION; HEART; ISOLATION AND PURIFICATION; LEWIS RAT; LUNG; SALIVARY GLAND; SPLEEN; TRANSPLANTATION; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HEART; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LECTINS, C-TYPE; LUNG; RATS; RATS, INBRED LEW; SALIVARY GLANDS; SPLEEN; TRANSPLANTS; URIDINE; VIRAL PROTEINS;

EID: 33644852794     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01152.x     Document Type: Article

References (19)

1. Alford CA Britt WJ Cytomegalovirus In Roizman B Whitley RJ Lopez C eds The Human Herpesviruses New York Raven Press 1993 227 255
2. Grattan MT Moreno-Cabral CE Starnes VA Oyer PE Stinson EB Shumway NE Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 1989 261 3561 3566
3. von Willebrand E Pettersson E Ahonen J Häyry P CMV infection, class II antigen expression, and human kidney allograft rejection Transplantation 1986 42 364 367
4. Williams JW Mital D Chong A et al Experiences with leflunomide in solid organ transplantation Transplantation 2002 73 358 366
5. Bartlett RR Dimitrijevic M Mattar T et al Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection Agents Actions 1991 32 10 21
6. Xu X Williams J Bremer E Finnegan A Chong A Inhibition of protein tyrosine phosphorylation in T cells by novel immunosuppressive agent, leflunomide J Biol Chem 1995 270 12398 12403
7. Elder RT Xu X Williams JW Gong H Finnegan A Chong AS-F The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms J Immunol 1997 159 22 27
8. Williamson RA Yea CM Robson PA et al Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound J Biol Chem 1995 270 22467 22472
9. Waldman WJ Knight DA Lurain NS et al Novel mechanism of inhibition of CMV by the experimental immunosuppressive agent leflunomide Transplantation 1999 68 814 825
10. Knight DA Hejmanowski AQ Dierksheide JE Williams JW Chong AS-F Waldman WJ Inhibition of herpes simplex type 1 by the experimental immunosuppressive agent leflunomide Transplantation 2001 71 170 174
11. Zeng H Waldman WJ Yin DP et al Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats Transplantation 2005 79 17 22
12. Bruggeman CA Debie WMH Grauls G Majoor G Van Boven CPA Infection of laboratory rats with a new cytomegalo-like virus Arch Virol 1983 76 189 199
13. Ono K Lindsey ES Improved technique of heart transplantation in rats J Throac Cardiovasc Surg 1969 57 225 229
14. Kaptein SJF Beuken E Grauls GELM Bruggeman C Vink C Rat cytomegalovirus open reading frame R44 is an early-late gene that encodes a nuclear protein Arch Virol 2001 146 2211 2218
15. Hsu SM Raine L Fsuger H et al Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J Histochem Cytochem 1981 29 577
16. Chong AS Huang W Liu L et al In vivo activity of leflunomide. Pharmacokinetic analyses and mechanism of immunosuppression Transplantation 1999 68 100 109
17. Williams JW Xiao F Foster P et al Leflunomide in experimental transplantation: control of rejection and alloantibody production, reversal of acute rejection and interaction with cyclosporine Transplantation 1994 57 1223 1231
18. Avery RK Bolwell BJ Yen-Lieberman B et al Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection Bone Marrow Transplant 2004 34 1071 1075
19. John GT Manivannan J Chandy S Peter S Jacob CK Leflunomide therapy for cytomegalovirus disease in renal allograft recipients Transplantation 2004 77 1460 1461